Answers are grounded in this paper and cite their sources.
Background: This study aims to identify clinical factors associated with prolonged invasive mechanical ventilation (IMV; ≥7 days) in neonates with acute respiratory distress syndrome (ARDS). Methods: This multicenter retrospective observational cohort study included neonates with ARDS admitted to neonatal intensive care units (NICUs) at 17 tertiary hospitals between March 2022 and June 2025. Neonates were classified according to cumulative IMV duration into a prolonged IMV group (≥7 days) and a non-prolonged IMV group (<7 days). Student t test, the Wilcoxon rank-sum test, the χ 2 test or Fisher exact test, and multivariable bidirectional stepwise logistic regression were used to identify associated factors. Results: Among 752 enrolled neonates, 77 with missing IMV duration data and 34 who died, had treatment withdrawn, or were discharged before treatment completion were excluded, leaving 641 neonates for the primary analysis. In the univariable analysis, antenatal glucocorticoid exposure, birth weight, 1-minute Apgar score, ARDS severity, first fraction of inspired oxygen, first mean airway pressure, first oxygenation index (OI) after admission, air leak syndrome, persistent pulmonary hypertension of the newborn, intraventricular hemorrhage, patent ductus arteriosus, and sepsis differed between the prolonged IMV and non-prolonged IMV groups (all P < 0.05). Multivariable analysis showed that a lower 1-minute Apgar score (odds ratio [OR]: 0.83, 95% confidence interval [CI]: 0.75–0.92), higher first OI after admission (OR: 1.04; 95% CI: 1.01–1.06), and persistent pulmonary hypertension of the newborn (OR: 3.77; 95% CI: 2.33–6.09) were independently associated with prolonged IMV. Gestational age showed a borderline inverse association (OR: 0.87; 95% CI: 0.76–1.00). Conclusion: A lower 1-minute Apgar score and a higher first OI after admission were independently associated with prolonged IMV. These observational findings do not establish causality. These findings primarily apply to neonates with evaluable treatment courses and should not be extrapolated to overall mortality or prognosis.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: